L01AA09 |
B |
Bendamustine HCl - 100mg |
7587 |
186958/14 |
RIBOMUSTIN |
100mg |
1 |
Injectable powder for concentrate for solution |
Infusion |
Mersaco |
Haupt Pharma Wolfratshausen GmbH |
Germany |
31,939,807 L.L |
19.35 |
D |
Astellas Pharma GmbH |
Germany |
03/04/20 |
|
L01AA09 |
B |
Bendamustine HCl - 100mg |
11804 |
131123/1 |
RIBOMUSTIN |
100mg |
1 |
Injectable powder for concentrate for solution |
Infusion |
Mersaco |
Haupt Pharma Wolfratshausen GmbH |
Germany |
31,939,807 L.L |
19.35 |
D |
Pharmaand GmbH (Pharma & GmbH, Austria) |
Austria |
03/04/20 |
|
L01AA09 |
G |
Bendamustine HCl - 100mg |
9333 |
100717/1 |
BENDAVIVAL |
100mg |
1 |
Injectable concentrated powder for solution |
Infusion |
Abela Fr |
Thymoorgan Pharmazie GmbH |
Germany |
26,072,618 L.L |
19.35 |
D |
Hikma Pharmaceuticals |
Jordan |
03/04/20 |
|
L01AA09 |
G |
Bendamustine HCl - 100mg/50ml |
8943 |
151516/1 |
BENDAMUSTINE HYDROCHLORIDE |
100mg/50ml |
5vials x 50ml |
Injectable powder for concentrate for solution |
Infusion |
Mediterranean Pharmaceutical Company |
Accord Healthcare Limited |
UK |
78,439,178 L.L |
2.44 |
E2 |
Accord Healthcare Limited |
UK |
03/04/20 |
|
L01AA09 |
G |
Bendamustine HCl - 100mg/50ml |
11631 |
113622/1 |
BENDAMUSTINE HYDROCHLORIDE GP PHARM |
100mg/50ml |
5vials x 50ml |
Injectable powder for concentrate for solution |
Infusion |
Mediterranean Pharmaceutical Company |
GP-Pharm, SA |
Argentine |
78,439,178 L.L |
2.44 |
E2 |
Pharminicio SL |
Spain |
03/04/20 |
|